| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.3 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -0.33 | 0.3 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |